newsfilter
← Latest News
GlobeNewswire·

Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

  • Optimi Health Corp. will participate in the H.C. Wainwright 28th Annual Global Investment Conference held September 14-16, 2026, at the Lotte New York Palace Hotel.
  • A company presentation will be available on demand starting Friday, September 11, 2026, at 7:00 a.m. ET.
  • Management will be available for one-on-one meetings throughout the conference; interested investors should contact H.C. Wainwright representatives, email meetings@hcwco.com, or register for the event.
  • Optimi Health Corp. is a commercial-stage pharmaceutical manufacturer licensed by Health Canada to produce GMP-grade MDMA & botanical psilocybin drug products at its British Columbia facilities.
  • The company supplies active pharmaceutical ingredients & finished dosage forms to international regulated clinical programs, with products currently prescribed in Australia under the Authorized Prescriber Scheme & accessible in Canada via the Special Access Program.